Spielberg ’s Secret
This essay describes how a podcast inspired a physician ’s new approach to complimenting patients and colleagues and the benefits gained. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - November 13, 2023 Category: Internal Medicine Source Type: research

Utility of a Novel Trainee-Level Hematology/Oncology Podcast in Graduate Medical Education: a Pilot Study
AbstractAsynchronous learning continues to gain popularity in medical education. One medium to facilitate asynchronous learning is the podcast. Currently, there are a limited number of hematology/oncology (H/O) podcasts geared towards residents and fellows ( “trainees”). To address this need, we created a series of podcasts covering fundamental H/O topics for H/O fellows and internal medicine residents rotating on H/O services. We evaluate the effectiveness of this approach in this pilot study. Between September 2022 and February 2023, residents rec eived recommended episodes via email prior to their rotation. Followin...
Source: Journal of Cancer Education - November 11, 2023 Category: Cancer & Oncology Source Type: research

---
On The Dose podcast, Vikas Saini, M.D., discusses strategies for tackling overtreatment in health care so that resources can be channeled to the right place.        (Source: The Commonwealth Fund: Publications)
Source: The Commonwealth Fund: Publications - November 10, 2023 Category: International Medicine & Public Health Source Type: research

Podcast on Self-administered Intranasal Etripamil for Symptomatic Paroxysmal Supraventricular Tachycardia: The RAPID Trial
AbstractParoxysmal supraventricular tachycardia (PSVT) is commonly seen in clinical practice and represents a significant burden to the healthcare system and to patients. First-line treatments include calcium channel blockers (CCB), although they are intravenous and require medical supervision. Etripamil is an investigational self-administered intranasal L-type CCB for unsupervised treatment of PSVT. In this podcast, we discuss the RAPID trial (NCT03464019), which was a phase 3 study that evaluated the safety and efficacy of etripamil in terminating PSVT episodes using a repeat-dosing regimen. RAPID was a multicenter, rand...
Source: Cardiology and Therapy - November 10, 2023 Category: Cardiology Source Type: research